Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Sotac Pharmaceuticals Limited

NSE: SOTAC · Pharmaceuticals & Biotechnology · 10 announcements

Share price
₹90.05
Market cap
₹99.51 Cr
Revenue (annual)
₹101.2 Cr
Net profit (annual)
₹6.29 Cr
P/E (TTM)
15.8×Sector 47.4×
Promoter holding
72.85%
FII holding
16.79%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:31 IST NSE
Other Announcement

Sotac Pharmaceuticals Other Announcement

Sotac Pharmaceuticals Limited submitted its annual SDD Compliance Certificate for the year ended March 31, 2026. The filing confirms regulatory compliance under PIT Regulations.

12:15 IST NSE
Other Announcement

Sotac Pharmaceuticals Other Announcement

Sotac Pharmaceuticals Limited informed the NSE that it is exempt from filing quarterly Corporate Governance Reports under SEBI Regulation 27(2). The exemption applies because the company's equity shares are listed on the NSE SME Emerge Platform, meeting the non-applicability criteria under Regulation 15(2)(b).